Cargando…

Intermittent fasting and changes in clinical risk scores: Secondary analysis of a randomized controlled trial

BACKGROUND: Intermittent fasting may increase longevity and lower cardiometabolic risk. This study evaluated whether fasting modifies clinical risk scores for mortality [i.e., Intermountain Mortality Risk Score (IMRS)] or chronic diseases [e.g., Pooled Cohort Risk Equations (PCRE), Intermountain Chr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Horne, Benjamin D., Anderson, Jeffrey L., May, Heidi T., Le, Viet T., Bair, Tami L., Bennett, Sterling T., Knowlton, Kirk U., Muhlestein, Joseph B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505676/ https://www.ncbi.nlm.nih.gov/pubmed/37727698 http://dx.doi.org/10.1016/j.ijcrp.2023.200209

Ejemplares similares

Preferential Metabolic Improvement by Intermittent Fasting in People with Elevated Baseline Red Cell Distribution Width: A Secondary Analysis of the WONDERFUL Randomized Controlled Trial
por: Horne, Benjamin D., et al.
Publicado: (2021)

Association of periodic fasting with lower severity of COVID-19 outcomes in the SARS-CoV-2 prevaccine era: an observational cohort from the INSPIRE registry
por: Horne, Benjamin D, et al.
Publicado: (2022)

DOES ABO BLOOD GROUP INFLUENCE RISK OR SEVERITY OF COVID-19?
por: Anderson, Jeffrey L., et al.
Publicado: (2021)

ROUTINE PERIODIC FASTING IS ASSOCIATED WITH A LOWER RISK OF INPATIENT HOSPITALIZATION FOR THE PRIMARY DIAGNOSIS OF HEART FAILURE FOLLOWING COVID-19 DIAGNOSIS
por: Horne, Benjamin Davies, et al.
Publicado: (2023)

Is Alcohol Consumption Associated with a Lower Risk of Cardiovascular Events in Patients Treated with Statins? An Observational Real-World Experience
por: Anderson, Jeffrey L., et al.
Publicado: (2022)

A COMPARISON OF CARDIOVASCULAR OUTCOMES AMONG SARS-COV-2 POSITIVE PATIENTS, SARS-COV-2 NEGATIVE PATIENTS, AND A HISTORICAL COHORT
por: May, Heidi Thomas, et al.
Publicado: (2023)

Frequency and Outcomes of Patients Presenting with Non-ST Elevation Myocardial Infarction (NSTEMI) without Standard Modifiable Risk Factors: A US Healthcare Experience
por: Anderson, Jeffrey L., et al.
Publicado: (2023)

Association of Sociodemographic Factors and Blood Group Type With Risk of COVID-19 in a US Population
por: Anderson, Jeffrey L., et al.
Publicado: (2021)

IMPACT OF THE COVID PANDEMIC ON DEPRESSIVE SYMPTOMS AND SEVERITY
por: May, Heidi Thomas, et al.
Publicado: (2023)

Cardiovascular Outcomes of ST-Elevation Myocardial Infarction (STEMI) Patients without Standard Modifiable Risk Factors (SMuRF-Less): The Intermountain Healthcare Experience
por: Anderson, Jeffrey L., et al.
Publicado: (2022)

Real-world clinical burden and economic assessment associated with hyperkalaemia in a large integrated healthcare system: a retrospective analysis
por: Muhlestein, Joseph B., et al.
Publicado: (2022)

Frequency and clinical impact of hyperkalaemia within a large, modern, real‐world heart failure population
por: Muhlestein, Joseph B., et al.
Publicado: (2020)

Randomized controlled trial of once-per-week intermittent fasting for health improvement: the WONDERFUL trial
por: Bartholomew, Ciera L, et al.
Publicado: (2021)

Pilot Study of Novel Intermittent Fasting Effects on Metabolomic and Trimethylamine N-oxide Changes During 24-hour Water-Only Fasting in the FEELGOOD Trial
por: Washburn, Rachel L., et al.
Publicado: (2019)

Association of the Intermountain Risk Score with major adverse health events in patients positive for COVID-19: an observational evaluation of a US cohort
por: Horne, Benjamin D, et al.
Publicado: (2022)

A Small but Significantly Greater Incidence of Inflammatory Heart Disease Identified After Vaccination for Severe Acute Respiratory Syndrome Coronavirus 2
por: Knowlton, Kirk U, et al.
Publicado: (2021)

Economics and outcomes of sotalol in‐patient dosing approaches in patients with atrial fibrillation
por: Varela, Daniel L., et al.
Publicado: (2022)

A new ratio for better predicting future death/myocardial infarction than standard lipid measurements in women >50 years undergoing coronary angiography: the apolipoprotein A1 remnant ratio (Apo A1/ [VLDL(3)+IDL])
por: May, Heidi T, et al.
Publicado: (2013)

Higher docosahexaenoic acid levels lower the protective impact of eicosapentaenoic acid on long-term major cardiovascular events
por: Le, Viet T., et al.
Publicado: (2023)

Improving CHA(2)DS(2)-VASc stratification of non-fatal stroke and mortality risk using the Intermountain Mortality Risk Score among patients with atrial fibrillation
por: Graves, Kevin G, et al.
Publicado: (2018)

Atrial fibrillation is a risk factor for major adverse cardiovascular events in COVID-19
por: Cutler, Michael J., et al.
Publicado: (2022)

Repeated Measurement of the Intermountain Risk Score Enhances Prognostication for Mortality
por: Horne, Benjamin D., et al.
Publicado: (2013)

STATIN USE AT TIME OF RESPIRATORY VIRAL INFECTION IN PATIENTS WITH PRIOR HISTORY OF CARDIOVASCULAR DISEASE AND RISK OF SUBSEQUENT CARDIOVASCULAR EVENTS
por: Knight, Stacey, et al.
Publicado: (2015)

Clinically feasible stratification of 1-year to 3-year post-myocardial infarction risk
por: Horne, Benjamin D, et al.
Publicado: (2018)

The Summit Score Stratifies Mortality and Morbidity in Chronic Obstructive Pulmonary Disease
por: Horne, Benjamin D, et al.
Publicado: (2020)

Clinical Management of Intermittent Fasting in Patients with Diabetes Mellitus
por: Grajower, Martin M., et al.
Publicado: (2019)

Impact of anticoagulation therapy on the cognitive decline and dementia in patients with non‐valvular atrial fibrillation (cognitive decline and dementia in patients with non‐valvular atrial fibrillation [CAF] trial)
por: Bunch, Thomas Jared, et al.
Publicado: (2022)

A highly predictive cardiac positron emission tomography (PET) risk score for 90-day and one-year major adverse cardiac events and revascularization
por: McCubrey, Raymond O., et al.
Publicado: (2022)

Vitamin D supplementation protects against reductions in plasma 25‐hydroxyvitamin D induced by open‐heart surgery: Assess‐d trial
por: Barker, Tyler, et al.
Publicado: (2021)

Considerations for the Optimal Timing, Duration, Frequency, and Length of an Intermittent Fasting Regimen for Health Improvement
por: Horne, Benjamin D.
Publicado: (2020)

Editorial: Intermittent fasting and time-restricted eating in health, physical performance, and disease prevention
por: Horne, Benjamin D., et al.
Publicado: (2023)

Short‐Term Exposure to Fine Particulate Matter Air Pollution Is Preferentially Associated With the Risk of ST‐Segment Elevation Acute Coronary Events
por: Pope, C. Arden, et al.
Publicado: (2015)

Pathogenic Mechanisms of the Severe Acute Respiratory Syndrome Coronavirus 2 and Potential Direct and Indirect Counteractions by Intermittent Fasting
por: Horne, Benjamin D., et al.
Publicado: (2022)

Effect of Vascepa (icosapent ethyl) on progression of coronary atherosclerosis in patients with elevated triglycerides (200–499 mg/dL) on statin therapy: Rationale and design of the EVAPORATE study
por: Budoff, Matthew, et al.
Publicado: (2018)

Importance of Intermittent Fasting Regimens and Selection of Adequate Therapy on Inflammation and Oxidative Stress in SARS-CoV-2 Infection
por: Ezzati, Armin, et al.
Publicado: (2022)

Antithrombotic Therapy in Patients with Acute Coronary Syndrome in the Intermountain Heart Collaborative Study
por: Knight, Stacey, et al.
Publicado: (2015)

Intermittent Fasting and Metabolic Health
por: Vasim, Izzah, et al.
Publicado: (2022)

Intermittent Fasting in Cardiovascular Disorders—An Overview
por: Malinowski, Bartosz, et al.
Publicado: (2019)

The Role of Intermittent Fasting in Parkinson's Disease
por: Neth, Bryan J., et al.
Publicado: (2021)

Effects of Intermittent Fasting on Brain Metabolism
por: Brocchi, Alex, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_46l00iqs18bdm6e9ng0aoct3er